Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2014-005431-13Phase 4Completed
Phase 4, randomised, double-blind trial comparing Intranasal Syntocinon with Placebo nasal spray (2 arms). Primary endpoint: Maternal sensitivity on Emotional Availability Scales. Started Dec 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2014-005431-13.